Conference Proceedings
Home
 > 
Browse by Publisher
 > 
BCC Research LLC
 > 
Anti-Parkinson's Drugs: Global Markets to 2022

Anti-Parkinson's Drugs: Global Markets to 2022

Send a Friend    
Anti-Parkinson's Drugs: Global Markets to 2022
Item #: PHM193A
Our Price:   
$2,750.00
Pricing: 
Product Description
Title:Anti-Parkinson's Drugs: Global Markets to 2022
Report Code:PHM193A
Pages:172
Format:PDF
Publisher:BCC Research LLC
Published:3/6/2018
Keywords:Anti-Parkinson's Drugs; Global Anti-Parkinson’s Drugs Market; 3D Printed Drugs; Anti-Parkinson's Drugs Market Characteristics; Anti-Parkinson's Drugs Market Trends and Strategies

Report Scope :

This research report categorizes the anti-Parkinson’s drugs market by type. Product types include low dopaminergic, dopamine agonists, enzyme inhibitors and other anti-Parkinson’s medications.

Report Includes:

- 95 data tables
- An overview of the global market for anti-Parkinson’s drugs and their future demand
- Analyses of global market trends, with data from 2013-2017, and projections of compound annual growth rates (CAGRs) through 2022
- Analyses of the major factors and technological advances such as biomarkers, 3D printed drugs, mobile applications and wearable technologies in the monitoring and treatment of Parkinson’s disease
- Discussion of the major segments of the anti-Parkinson’s drugs, i.e., dopaminergic drugs, dopamine agonists, enzyme inhibitors and other anti-Parkinson’s medications
- Company profiles of the major players in the market, including AbbVie, Mylan Laboratories, Valeant Pharmaceuticals and Novartis

Related Products
Browse By PublisherShop By Category
Dave A Curran, EzineArticles.com Basic Author